Metoprolol Improves Left Ventricular Longitudinal Strain at Rest and during Exercise in Obstructive Hypertrophic

Anne M Dybro1, Torsten B Rasmussen1, Roni R Nielsen1

  • 1Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark; Department of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark.

Insights

Beta-blocker treatment with metoprolol improved left ventricular global longitudinal strain (GLS) during exercise in patients with obstructive hypertrophic cardiomyopathy (HCM). This indicates a beneficial effect on systolic function, despite resting impairments.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Pharmacology

Background:

  • Obstructive hypertrophic cardiomyopathy (HCM) can cause exertional heart failure symptoms.
  • Left ventricular (LV) ejection fraction may not fully capture systolic dysfunction in HCM.
  • Longitudinal strain (LS) is a sensitive marker for LV systolic dysfunction in HCM.

Purpose of the Study:

  • To characterize LV segmental and global longitudinal strain (GLS) at rest and during exercise in obstructive HCM.
  • To evaluate the effect of beta-blocker treatment on LV systolic performance in these patients.

Main Methods:

  • A double-blind, placebo-controlled, randomized crossover trial involving 29 patients with obstructive HCM.
  • Patients received metoprolol or placebo for two 2-week periods.
  • Echocardiography with speckle-tracking-derived LS assessed at rest and peak exercise.

Main Results:

  • Resting LV segmental LS showed an apical-basal difference, with severely abnormal basal segments.
  • Metoprolol treatment improved LS in apical and mid segments compared to placebo.
  • During peak exercise, metoprolol was associated with improved LV GLS.

Conclusions:

  • LV GLS is impaired at rest and during exercise in obstructive HCM.
  • Metoprolol treatment demonstrated a beneficial effect on LV systolic function during exercise.
  • Beta-blockers may improve exercise capacity and symptoms in obstructive HCM patients.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
25
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
412
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
26
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
18
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
25